Adalimumab
A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.
Year introduced: 2016 (2002)
PubMed search builder options
Subheadings:
Tree Number(s): D12.776.124.486.485.114.224.060.250, D12.776.124.790.651.114.224.060.250, D12.776.377.715.548.114.224.200.250
MeSH Unique ID: D000068879
Registry Number: FYS6T7F842
Entry Terms:
- Humira
- Amjevita
- Cyltezo
- D2E7 Antibody
- Antibody, D2E7
- Adalimumab-atto
- Adalimumab-adbm
See Also:
Pharmacologic Action: